Differences in emphasis in AD research
 

I thought this was interesting.

It shows a change in emphasis in NIH funding allocations to AD research between 2008 and 2017.

It shows less emphasis on β-amyloid and more on "Other", genetics, vascular and bioenergetic work.

Given the complexity of AD this looks sensible to me.

The Alzheimer’s gamble: NIH tries to turn billions in new funding into treatment for deadly brain disease | Science | AAAS